Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.540, 2007-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sitagliptin tops rosiglitazone for type 2 diabetes
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Access to resources
Recommend
Sitagliptin sweetens the options in type 2 diabetes
Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. :
The sweet and sour RECORD of rosiglitazone for type 2 diabetes
Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. :
Rosiglitazone: a new therapy for Type 2 diabetes
By Greene D.A.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. :
Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus
Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. :